EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. (2011)

First Author: Lupberger J

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nm.2341

PubMed Identifier: 21516087

Publication URI: http://europepmc.org/abstract/MED/21516087

Type: Journal Article/Review

Volume: 17

Parent Publication: Nature medicine

Issue: 5

ISSN: 1078-8956